Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation

Bone Marrow Transplantation

Volumn 25, Issue 10, 2000, Pages 1067-1071

  Busca, A ^a   Saroglia, E M ^a   Lanino, E ^b   Manfredini, L ^b   Uderzo, C ^e   Nicolini, B ^c   Messina, C ^d   Rabusin, M ^f   Miniero R ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d Department of Pediatrics ^*

^e UNIVERSITY OF TURIN   (Italy)

^f MOLINETTE HOSPITAL   (Italy)

Author keywords

Chronic GVHD; Mycophenolate mofetil; Pediatric bone marrow transplantation

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADRENOLEUKODYSTROPHY; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FANCONI ANEMIA; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LIVER TOXICITY; MALE; MOUTH DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SIBLING; SKIN DISEASE;

EID: 0034102824     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702410     Document Type: Article

References (18)

1. Ferrara JLM, Deeg HJ. Graft-versus-host disease. Neu- Engl J Med 1991:324:667-674.
2. Locatelli F, Uderzo C, Dini G et al. Graft-versus-host disease in children: the AIEOP-BMT Group experience with cyclosporine A. Bone Marrow Transplant 1993; 12: 627-633.
3. Sullivan KM, Witherspoon RP, Storb R et al Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-versus-host disease. Blood 1998; 72: 555-561.
4. Schiller G, Gale RP. Is there an effective therapy for chronic graft-versus-host disease? Bone Marrow Transplant 1993; 11: 189-192.
5. Basara N, Blau \VI, Romer E et al. Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients. Bone Marrow Transplant 1998; 22: 61-65.
6. Nash RA, Furlong T, Storb R et al. Mycophenolate mofetil (MMF) as salvage treatment for graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT): safety analysis. Blood 1997; 90 (Suppl. 1): 105a.
7. Mookerjee B, Altomonte V, Vogelsang G. Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus. Bone Marrow Transplant 1999; 24: 517-520.
8. Sullivan KM. Graft-versus-host disease. In: Forman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific: Boston, 1994, p 353.
9. Hebert MF, Ascher NL, Lake JR et al. Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients. Transplantation 1999; 67: 707-712.
10. Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients: US Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 1995; 60: 225-232.
11. Sweeney MJ, Huffman DH, Esterman MA. Metabolism and biochemistry of mycophenolic acid. Cancer Res 1972; 32: 1803-1808.
12. Franklin TJ, Cook JM. The inhibition of nucleic acid synthesis by mycophenolic acid. Biochem J 1969; 113: 515-517.
13. Yu C, Seidel K, Nash RA el ai. Synergism between mycophenolate mofetil and cyclosporine in preventing graft-versushost disease among lethally irradiated dogs given DLA-nonidentical unrelated marrow grafts. Blood 1998; 91: 2581-2587.
14. van Leeuwen L, Guiffre AK, Sewell WA et al. Administration of mycophenolate mofetil in a murine model of acute graftversus-host disease after bone marrow transplantation. Transplantation 1998; 64: 1097-2002.
15. Bomhauser M, Schuler U, Porksen G et al. Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation. Transplantation 1999; 67: 499-504.
16. Mirkovich A, Eugui EM. Prevention of murine graft-versushost disease (GVHD) by mycophenolate mofetil (CellCept). 9th International Conaress of Immunology, San Francisco, July 1995: 426.
17. Mathew TH, for the Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation. Transplantation 1998; 65: 1450-1454.
18. Atkinson K, Rarewell V, Storb R et al. Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graftversus-host disease. Blood 1982; 60: 714-720.